NK-1R receptor antagonist (Hamlet BioPharma)

N/A

Report date: 2025/06/11 10:30:48
NME

Base Information

Drug NameNK-1R receptor antagonist (Hamlet BioPharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptor
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHamlet BioPharma AB
China Registration ClassN/A

Develop Information

Active CompaniesHamlet BioPharma AB
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A